Compare TRIB & AIDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TRIB | AIDX |
|---|---|---|
| Founded | 1992 | N/A |
| Country | Ireland | United States |
| Employees | N/A | 14 |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Precision Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1M | 6.7M |
| IPO Year | 1996 | N/A |
| Metric | TRIB | AIDX |
|---|---|---|
| Price | $12.45 | $0.46 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 724.2K | 213.0K |
| Earning Date | 05-22-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $13.51 | N/A |
| Revenue Next Year | $13.14 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.28 | $0.45 |
| 52 Week High | $9.85 | $14.09 |
| Indicator | TRIB | AIDX |
|---|---|---|
| Relative Strength Index (RSI) | 98.39 | 31.67 |
| Support Level | $0.64 | N/A |
| Resistance Level | N/A | $0.70 |
| Average True Range (ATR) | 0.53 | 0.04 |
| MACD | 1.23 | 0.01 |
| Stochastic Oscillator | 95.82 | 17.79 |
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has three segments, namely the Americas, Asia/Africa, and Europe, from which it derives a majority of its revenue from the Americas segment.
20/20 Biolabs Inc is a commercial stage diagnostics company with the core mission of developing and commercializing clinical laboratory tests for early disease detection and prevention and associated software that is powered by machine learning and real-world data to improve diagnostic accuracy and clinical utility. The company offers two OneTest lab products; OneTest for Cancer that inludes primary MCED blood test and revenue source post-COVID and OneTest for Longevity that consists of inflammatory biomarkers.